Your browser doesn't support javascript.
loading
Compliance with a WHO guideline for cardiovascular disease prevention. A population based cross-sectional study in Argentina.
Gulayin, Pablo; Gutierrez, Laura; Lanas, Fernando; Mores, Nora; Ponzo, Jacqueline; Calandrelli, Matías; Poggio, Rosana; Irazola, Vilma.
Afiliación
  • Gulayin P; Instituto de Efectividad Clínica y Sanitaria. pgulayin@iecs.org.ar.
  • Gutierrez L; Instituto de Efectividad Clínica y Sanitaria, Buenos Aires, Argentina. lgutierrez@iecs.org.ar.
  • Lanas F; CIGES, Universidad de La Frontera (UFRO), Temuco, Chile. lanastomas@gmail.com.
  • Mores N; Municipalidad de Marcos Paz, Buenos Aires, Argentina. oliveramores@gmail.com.
  • Ponzo J; Facultad de Medicina, Universidad de la República, Montevideo, Uruguay . ponzo4@gmail.com.
  • Calandrelli M; Sociedad Argentina de Cardiología. matiascalandrelli@yahoo.com.ar.
  • Poggio R; Consejo Nacional de Investigaciones Científicas y Técnicas de Argentina. rpoggio@iecs.org.ar.
  • Irazola V; departamento de Investigación en Enfermedades Crónicas del Instituto de Efectividad Clínica y Sanitaria. virazola@iecs.org.ar.
Rev Fac Cien Med Univ Nac Cordoba ; 81(1): 96-114, 2024 03 27.
Article en En | MEDLINE | ID: mdl-38537096
ABSTRACT

INTRODUCTION:

Current recommendations for cardiovascular disease (CVD) prevention are guided CVD risk classification. This study aims to analyze the level of compliance with pharmacological and non-pharmacological recommendations outlined in the World Health Organization (WHO) CVD prevention clinical practice guideline within the general population of two cities in Argentina.

METHODS:

We analyzed the compliance with preventive recommendations from the WHO 2007 Guidelines for Management of Cardiovascular Risk in two cities of Argentina participating in the CESCAS population-based study in the Southern Cone of Latin America.

RESULTS:

3990 participants were included. Considering the WHO recommendations, the use of antiplatelet medication was 5.6% (95% CI 3.5, 8.9) in primary prevention and 20.5% (95%= CI 16.0, 25.9) in secondary prevention. Regarding lipid-lowering medication, it was 6.7% (CI 95%= 4.4, 10.1) and 15.4% (CI 95%= 11.6, 20.1), respectively. As per non-pharmacological recommendations in the general population low intake of fruit and vegetables was 78.4% (CI 95%= 76.8, 79.9); low physical activity was 26.9% (CI 95%= 25.3, 28.5), current cigarette smoking was 28.3% (CI 95%= 26.6, 30.0), overweight/obesity was 73.9% (CI 95%= 72.3, 75.6), and excessive alcohol intake was 2.6% (CI 95%= 2.1, 3.4).

CONCLUSIONS:

It was observed a significantly low compliance with pharmacological and non-pharmacological recommendations for CVD prevention in the general population of two cities in Argentina. Urgent efforts are needed to improve compliance to cardiovascular preventive recommendations promoted by CPG, especially in Low- and Middle- Income Countries.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Enfermedades Cardiovasculares Límite: Humans País/Región como asunto: America do sul / Argentina Idioma: En Revista: Rev Fac Cien Med Univ Nac Cordoba Año: 2024 Tipo del documento: Article Pais de publicación: Argentina

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Enfermedades Cardiovasculares Límite: Humans País/Región como asunto: America do sul / Argentina Idioma: En Revista: Rev Fac Cien Med Univ Nac Cordoba Año: 2024 Tipo del documento: Article Pais de publicación: Argentina